WRIGHT LISA 4

4 · Vericel Corp · Filed May 2, 2025

Form 4

Period: 2025-04-30

Director

Transactions

Exercise/Conversion
Common Stock
2025-04-30+3,200→ 12,651 total
Award
Stock Option (Right to Buy)
2025-04-30+8,000→ 8,000 total
Exercise: $38.02Exp: 2035-04-30→ Common Stock (8,000 underlying)
Exercise/Conversion
Restricted Stock Unit
2025-04-30+3,200→ 0 total
→ Common Stock (3,200 underlying)
Award
Restricted Stock Unit
2025-04-30+3,200→ 3,200 total
→ Common Stock (3,200 underlying)

Footnotes (7)

[F1]The Restricted Stock Units (RSUs) converted to Phantom Stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date.
[F2]Upon the vesting of RSUs granted to the Reporting Person on May 1, 2024, the Reporting Person deferred the receipt of 3,200 shares of Common Stock and instead received 3,200 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan.
[F3]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
[F4]These RSUs vest 100% on the earlier of May 1, 2025, or the date of the first Annual Meeting of Stockholders following May 1, 2024.
[F5]No expiration date for this type of award.
[F6]The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
[F7]These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.

Documents

1 file